C4 Therapeutics (CCCC) Prepaid Assets (2019 - 2026)
C4 Therapeutics (CCCC) posted quarterly Prepaid Assets of $6.8 million for Q1 2026, down 27.63% year-over-year from $9.4 million in Q1 2025, and down 4.95% quarter-over-quarter from $7.2 million in Q4 2025.
C4 Therapeutics (CCCC) Prepaid Assets (2019 - 2026) Analysis & Trends
C4 Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 27.63% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (down 27.63% YoY), while the FY2025 annual figure was $7.2 million, down 26.52% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.8 million, down from $7.2 million in the prior quarter.
- The five-year high for Prepaid Assets was $10.8 million in Q2 2024, with the low at $5.7 million in Q4 2023.
- The 5-year median for Prepaid Assets is $8.0 million (2025), against an average of $8.3 million.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 105.07% in 2022, then sank 42.51% in 2023.
- C4 Therapeutics' Prepaid Assets stood at $9.9 million in 2022, then tumbled by 42.51% to $5.7 million in 2023, then jumped by 70.98% to $9.8 million in 2024, then dropped by 26.52% to $7.2 million in 2025, then dropped by 4.95% to $6.8 million in 2026.
- Business Quant data shows CCCC's Prepaid Assets at $6.8 million in Q1 2026, $7.2 million in Q4 2025, and $8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | C4 Therapeutics | 521.12 Mn | 267.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.91 Mn |
| Mar 31, 2026 | 6.82 Mn |
| Dec 31, 2025 | 7.17 Mn |
| Sep 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Dec 31, 2024 | 9.76 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 5.71 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | 6.07 Mn |
| Mar 31, 2023 | 7.60 Mn |
| Dec 31, 2022 | 9.93 Mn |
| Sep 30, 2022 | 10.32 Mn |
| Jun 30, 2022 | 8.88 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | 10.69 Mn |
| Sep 30, 2021 | 5.38 Mn |